Intimation for re-appointment of MD
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts less than Nifty Microcap 250 and 2.0 pts less than its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
TCFC Finance's board approved unaudited results for Q1 FY26 (quarter ended June 30, 2025), reporting a profit after tax of ₹174.11 lakhs, a sharp turnaround from a loss of ₹303.55 lakhs in the same quarter last year. Total revenue from operations rose to ₹658.58 lakhs, driven largely by net gains on fair value changes of ₹604.55 lakhs. Total assets stood at ₹11,965.58 lakhs and EPS came in at ₹1.66. The board also approved the re-appointment of Mrs. Tania Deol as Managing Director and CEO for another 5-year term (July 1, 2026 to July 1, 2031), subject to shareholder approval. Additionally, a reduction of share capital was approved, and the register of members will be closed from September 16 to 26, 2025 for the 34th AGM.
Continuity at the top with the existing MD being re-appointed is generally a stability signal for shareholders. Profitability recovery in Q1 is encouraging, though earnings are heavily dependent on fair value gains. The share capital reduction could improve book value per share if approved, but terms are not yet disclosed.